Convalescent Plasma for High-Risk Covid-19 Patients who w | UPDATES IN MEDICINE
Convalescent Plasma for High-Risk Covid-19
Patients who were seen in emergency departments within 7 days after the onset of Covid-19 symptoms and were considered appropriate for discharge were randomly assigned to receive either convalescent plasma or placebo. Convalescent plasma did not prevent disease progression.
